Gushengtang Holdings Limited (HK:2273)
:2273
Want to see HK:2273 full AI Analyst Report?
2273 Stock Chart & Stats
HK$29.00
HK$0.95(3.47%)
At close: 4:00 PM EST
HK$29.00
HK$0.95(3.47%)
Day’s Range― - ―
52-Week RangeHK$25.00 - HK$39.00
Previous CloseN/A
Volume1.49M
Average Volume (3M)1.54M
Market Cap
HK$6.35B
Enterprise ValueHK$5.01B
Total Cash (Recent Filing)HK$1.15B
Total Debt (Recent Filing)HK$784.51M
Price to Earnings (P/E)17.5
Beta1.21
Next Earnings
Aug 25, 2026EPS Estimate
0.87Next Dividend Ex-DateN/A
Dividend Yield2.61%
Share Statistics
EPS (TTM)1.49
Shares Outstanding234,371,050
10 Day Avg. Volume1,228,922
30 Day Avg. Volume1,539,754
Financial Highlights & Ratios
PEG Ratio0.96
Price to Book (P/B)2.84
Price to Sales (P/S)1.90
P/FCF Ratio12.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$38.34Price Target Upside32.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.81
Revenue Forecast (FY)HK$3.75B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue And Profitability RecoveryThe company moved from a 2021 loss to consistent profits from 2022 onward, with revenue accelerating ~30% in 2024 and ~40% in 2025. Durable revenue and profit recovery supports long-term reinvestment in clinics, clinician recruitment and network expansion, strengthening market position and operational scale.
Improving Return On Equity And Capital BaseROE rising to ~16% indicates the business is generating stronger returns from its equity base, reflecting improved operating efficiency and profitable deployment of capital. Sustained higher ROE supports shareholder returns and provides scope to fund organic growth without heavy dilution or excessive external financing.
Positive Cash Generation HistoricallyHistorically strong cash conversion (FCF near 80–87% of net income) underpins the company’s ability to fund clinic capex, working capital needs and dividends from operations. This persistent cash generation provides financial flexibility to support multi-year expansion and absorb cyclical clinic demand swings.
Bears Say
Free Cash Flow Deterioration In 2025A sharp negative turn in FCF growth in 2025 signals meaningful stress in cash dynamics, potentially from working-capital shifts or higher capex. If sustained, weaker FCF growth constrains reinvestment, dividend capacity and debt servicing, reducing strategic flexibility over the medium term.
Margin Volatility And PressureVolatile EBITDA margins and a decline versus earlier gross-margin levels point to cost-mix shifts, pricing pressure or weaker operating leverage. Persistent margin instability can limit earnings scalability, reduce free cash generation and make long-term profitability outcomes less predictable for the clinic network model.
Rising Leverage In 2025An increase in debt and higher leverage in 2025, even from moderate levels, raises refinancing and interest-rate sensitivity. Elevated leverage reduces balance-sheet flexibility to buy clinics, invest in services or withstand demand shocks, making capital allocation and growth more constrained if operating performance slips.
Gushengtang Holdings Limited News
2273 FAQ
What was Gushengtang Holdings Limited’s price range in the past 12 months?
Gushengtang Holdings Limited lowest stock price was HK$25.00 and its highest was HK$39.00 in the past 12 months.
What is Gushengtang Holdings Limited’s market cap?
Gushengtang Holdings Limited’s market cap is HK$6.35B.
When is Gushengtang Holdings Limited’s upcoming earnings report date?
Gushengtang Holdings Limited’s upcoming earnings report date is Aug 25, 2026 which is in 95 days.
How were Gushengtang Holdings Limited’s earnings last quarter?
Gushengtang Holdings Limited released its earnings results on Mar 31, 2026. The company reported HK$1.124 earnings per share for the quarter, beating the consensus estimate of HK$1.079 by HK$0.046.
Is Gushengtang Holdings Limited overvalued?
According to Wall Street analysts Gushengtang Holdings Limited’s price is currently Undervalued.
Does Gushengtang Holdings Limited pay dividends?
Gushengtang Holdings Limited pays a Quarterly dividend of HK$0.35 which represents an annual dividend yield of 2.61%. See more information on Gushengtang Holdings Limited dividends here
What is Gushengtang Holdings Limited’s EPS estimate?
Gushengtang Holdings Limited’s EPS estimate is 0.87.
How many shares outstanding does Gushengtang Holdings Limited have?
Gushengtang Holdings Limited has 234,371,050 shares outstanding.
What happened to Gushengtang Holdings Limited’s price movement after its last earnings report?
Gushengtang Holdings Limited reported an EPS of HK$1.124 in its last earnings report, beating expectations of HK$1.079. Following the earnings report the stock price went down -0.51%.
Which hedge fund is a major shareholder of Gushengtang Holdings Limited?
Currently, no hedge funds are holding shares in HK:2273
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gushengtang Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.49%
12-Months-Change
Fundamentals
Return on Equity
15.36%
Trailing 12-Months
Asset Growth
14.29%
Trailing 12-Months
Company Description
Gushengtang Holdings Limited
Gushengtang Holdings Limited, an investment holding company, provides healthcare services and sells healthcare products. It also engages in the wholesale and retail of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. The company was incorporated in 2014 and is headquartered in Guangzhou, China.
2273 Stock 12 Month Forecast
Average Price Target
HK$38.34
▲(32.21% Upside)
Technical Analysis
Rici Healthcare Holdings Ltd.
―
Beauty Farm Medical & Health Industry, Inc.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---